This study was carried out to determine the prevalence of hepatitis B virus (HBV) 
Introduction
Infections with hepatitis B virus (HBV) and hepatitis C virus (HCV) are problems that are important to global public health and represent significant causes of morbidity and mortality worldwide 1 .
According to the World Health Organization (WHO) 2, 3 , approximately 360 million people are chronically infected with HBV around the world, and 170 million with HCV, and are at risk of developing cirrhosis and/or hepatocellular carcinoma 4 .
In Brazil, it is estimated that 15% of the population have been in contact with HBV and 6 million people are HBV or HCV chronic carriers 5 . Although several studies have been conducted on hepatitis B and C, especially on blood banks 6, 7, 8, 9, 10, 11, 12 , there are few studies carried out among the general population 13, 14, 15 , and due to territorial extension, and cultural and economic differences, the distribution of these diseases in the country differs among regions 16 .
Additionally, prevalence studies of HBV and HCV markers in southern Brazil, more specifically in the state of Santa Catarina, are scarce as well.
Chapecó is located in the western of the state of Santa Catarina, Southern Brazil. In previous studies it has been considered a region of high endemicity of hepatitis B, where vertical transmission played an important role in maintaining ARTIGO ARTICLE the epidemic. Horizontal transmission also occurs, especially among individuals aged below five years old, through mechanisms that are not yet totally clear 17 .
The hepatitis B vaccination began in 1989 in some regions of Brazil, directed primarily to specific groups. Some years later (1998), it became available in more regions and to children aged below one year old, as well as to high risk populations. Afterwards, the coverage of the vaccine was extended to health students, military personnel and adolescents up to 15 years old. Specifically in Santa Catarina, in 1993 the vaccination was recommended to children aged below four years old, and, in 1996, to children up to 15 years old. It was only in 2001 that the National Immunization Program was extended to the population up to 19 years old 18 .
The establishment of political health programs requires an awareness of the epidemiological profile of the population in question. In this way, the determination of the prevalence of HBV and HCV infection markers, as well as HBV immunization markers represent fundamental tools. Thus, there is an urgent need to determine the real profile of these infections, so as to, in case of need, establish more effective measures of prevention and awareness.
Hepatitis B and C share common transmission pathways, making it possible to investigate them simultaneously 19 . Is it well known that during the ages of between 10 and 16, there is an increase of risk practices which can lead to HBV and HCV infection, such as unprotected sexual relations, tattooing and body piercing 20 .
Therefore, this study had a main objective of establishing the prevalence of HBV infection and immunization markers and HCV infection markers in adolescents and elementary school students in the city of Chapecó.
Material and methods
This cross-sectional study included elementary school student volunteers, adolescents aged between 10 and 16, in Chapecó between March and July, 2008.
A random sampling plan was conducted for the selection of volunteers, so that it would reproduce the distribution of the adolescent population in elementary school (5 th -8 th grade), according to the administrative category of school of attendance, as well as their dimension and geographic location. Thus, 418 students from 21 schools were enrolled to participate in this study. This sample was considered sufficient to be representative of the student population in question and to determine a prevalence of HBV and HCV markers of 50% (unknown prevalence) with a 95% confidence interval (95%CI), and 0.05 alpha error 21 .
A 10mL blood sample was collected from each volunteer by venous puncture. Serology comprised HBsAg, anti-HBc, anti-HBs and anti-HCV. Every test was performed in the Municipal Clinical Analysis Laboratory of Chapecó, using automated Microparticle Enzyme Immunosorbant Assay (Abbott, AxSYM System, Wiesbaden, Germany).
HBsAg, anti-HBc and anti-HCV results were categorized as "reactive" or "nonreactive", strictly according to the manufacturer's instructions.
Protection with hepatitis B vaccination is considered to be achieved when the concentration of anti-HBs antibody titers is greater than or equal to 10IU/L 22, 23, 24 , thus, volunteers with anti-HBs titers greater than or equal to 10IU/L were considered immunized.
Statistical analysis consisted of inferential analysis of data for different proportions. 
Results
Among the 418 volunteers, 67.5% studied in public schools run by the state, 28.5% in public schools run by the city hall, and 4.1% in private schools. Regarding gender, 39% were male and 61% female.
The age of the participants varied from 10 to 16 years, with a mean age of 13.7 ± 1.3 years and median of 14 years. According to quartiles, age was distributed as follows: 10-12 years old (21.3%), 13 years old (19.9%), 14 years old (24.4%) and 15-16 years old (34.5%).
The prevalence of HBsAg was found to be 0.2% (95%CI: 0.0-1.3), and the prevalence of antiHBc was found to be 1.4% (95%CI: 0.5-3.1).
Regarding anti-HBs, 48.6% presented reactive titers, 39% presented detectable titers and 12.4% presented undetectable titers. Table 1 shows the profile of hepatitis B markers of infection and immunization according to gender.
None of the volunteers presented reactive results for anti-HCV (0%). It is also lower than that of 1% found in Pakistan 26 and of 4.3% in individuals from Thailand of a similar age range born before the implementation of the HBV vaccination, but similar to that of 0.7%, in those born afterwards 27 .
Our anti-HBc prevalence is lower than that reported in Northern Brazil, 6% in children aged below 19 years old 14 and in Southern Brazil among blood donors: 5.3% 7 and 9.2% 17 in Florianópolis and 29% in Chapecó 7 . It is also lower than that found in Thailand, in individuals of a similar age range born before the implementation of the HBV vaccination, 15.8%, and in individuals born afterwards, 2.9% 27 .
This lower prevalence for HBsAg and antiHBc found in our study may be due to the age range of volunteers, who are expected not to have much sexual exposition yet, neither involvement with injected drugs, as well as blood transfusions 28 . Additionally, it must be considered that the hepatitis B vaccination may have contributed to this lower prevalence, once mandatory vaccination was introduced in Chapecó in 1994, followed by mass vaccination campaigns which covered all the schools of the city. Therefore, all current city population aged below 25 years old were, theoretically, vaccinated against hepatitis B, including subjects sampled in the present study.
The results found in our study are in part justified by these facts, since a significant proportion (48.6%) of volunteers presented anti-HBs titers greater than or equal to 10IU/L and were, therefore, considered immunized against hepatitis B. Of the excessively, 39% presented detectable titers below 10IU/L and 12.4% presented undetectable titers of anti-HBs.
Several studies argue about the necessity of booster doses of the vaccine for those with antiHBs detectable titers below 10 UI/L. Also, there are authors who suggest that strong immunologic memory persists for more than 10 years once the complete vaccination scheme has been administered properly and therefore, an anamnestic anti-HBs response is achieved after HBV contact, even if anti-HBs titers are not higher than 10IU/L 29, 30, 31, 32, 33 . Thus, considering that our volunteers were vaccinated approximately 10 years ago, and that anti-HBs titers wane through the years even though immunologic memory persists, we can consider that the present research found that in Chapecó, there is a vaccine coverage of 87.6% (which corresponds to all subjects with detectable anti-HBs titers).
The coverage rate found in our study is higher than that found in Thailand, where 74.5% of children aged below 18 had received the vaccine, 5.1% had never received the vaccine and 20.4% had unknown vaccination status 27 . Although this coverage rate is lower than that expected by the Brazilian Ministry of Health (95%), it must be considered that the expected rates are based on the number of third doses administered, as opposed to the anti-HBs status, and that some percentage of the population may not respond to the hepatitis B vaccine.
Regarding hepatitis C, our study found no cases of reactivity (0%). This prevalence is lower than that of studies with populations of a similar age in Germany (0.7% and 0.8%) 34, 35 , and in the United States (0.3%) 36 . It is also lower that that found in Northern Brazil in volunteers aged below 19 years old (2.1%) 14 and in Pakistan in volunteers aged between 6 and 15 (9.6%) 37 , and corroborates that found in Spain (0%) in a population aged below 19 38 . As foreseeable, due to the young age of participants, our results show a low risk of hepatitis C infection.
It should be noted that all volunteers with reactivity for HBsAg, anti-HBc or undetectable titers of anti-HBs were directed to health units, to receive proper health care and/or immunization.
We acknowledge some limitations to our analysis. It was not possible to perform duplicate analysis or confirmatory tests to evaluate the confiability of our results. Additionally, we did not verify the vaccination cards of the volunteers and therefore, cannot guarantee that all subjects were preciously vaccinated; and possible immigration interferences and forms of exposition to the HBV were not investigated.
Conclusions
This study showed a low prevalence of HBV and HCV markers of infection among adolescent students at elementary schools in Chapecó. Moreover, a great number of volunteers presented anti-HBs titers, which clearly indicates that the National Program of Immunization for hepatitis B is being efficient in the region studied. Finally, our study shows the impact and importance of proper health campaigns and policies in turning a hepatitis B high endemicity area into a low endemicity one for children and adolescents. 
